Core Laboratories Inc. (CLB) Financial Statements
Industry: Oil & Gas Field Services (Other)
In fiscal 2025, Core Laboratories reported revenue of $526.5M, up 0.5% from $523.8M the year before. Net income was $29.7M (a 5.6% net margin), or $0.63 per diluted share. Gross margin was 20.7% and operating margin was 10.7%. Operating activities generated $37.0M of cash, leaving $25.8M of free cash flow. At fiscal year end, Core Laboratories held $584.0M in total assets against $318.0M in total liabilities, including $22.7M of cash and equivalents.
Open the full interactive Core Laboratories financials → Quarterly statements, key ratios, valuation history and price charts.
Core Laboratories Key Stats
| Share Price | $10.16 |
|---|---|
| Market Cap | $476.3M |
| P/E Ratio | 16.1 |
| Revenue YoY Growth | +0.5% |
| 52-Week Range | $9.70 – $19.63 |
| Shares Outstanding | 46.0 million (basic, 2026 Q2) |
Core Laboratories Income Statement
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Revenue | $509.8M | $523.8M | $526.5M |
| Cost of Goods Sold | $0 | $420.5M | $417.6M |
| Gross Profit | $509.8M | $103.3M | $108.9M |
| Operating Income | $54.6M | $58.6M | $56.5M |
| Pre-Tax Income | $41.2M | $46.2M | $45.9M |
| Income Tax | -$4.2M | $14.0M | $15.5M |
| Net Income | $36.7M | $31.4M | $29.7M |
| Diluted EPS | $0.77 | $0.66 | $0.63 |
Core Laboratories Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $134.5M | $138.3M | $121.8M | $124.6M |
| Net Income | $14.2M | $4.9M | -$789,000 | $6.0M |
| Diluted EPS | $0.30 | $0.11 | -$0.02 | $0.13 |
Core Laboratories Balance Sheet
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Cash & Equivalents | $15.1M | $19.2M | $22.7M |
| Current Assets | $223.1M | $226.6M | $214.7M |
| Total Assets | $586.4M | $590.4M | $584.0M |
| Current Liabilities | $88.1M | $97.6M | $106.0M |
| Total Long-Term Debt | $163.1M | $126.1M | $110.3M |
| Total Liabilities | $361.6M | $338.4M | $318.0M |
| Shareholders' Equity | $224.8M | $252.0M | $266.0M |
Core Laboratories Cash Flow Statement
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Cash From Operations | $24.8M | $56.4M | $37.0M |
| Cash From Investing | -$6.7M | -$6.4M | -$2.2M |
| Cash From Financing | -$18.4M | -$46.0M | -$31.3M |
| Free Cash Flow | $14.2M | $43.4M | $25.8M |
Figures from Core Laboratories' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Core Laboratories financials page for every line item.
Core Laboratories Company Profile
| Ticker | CLB |
|---|---|
| Exchange | NYSE |
| Industry | Oil & Gas Field Services (Other) |
| Headquarters | Houston, Texas |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001958086 |
Frequently Asked Questions
What was Core Laboratories' revenue in fiscal 2025?
Core Laboratories (CLB) reported revenue of $526.5M for fiscal 2025.
What is Core Laboratories' annual revenue history?
Core Laboratories' annual revenue by fiscal year: 2023: $509.8M; 2024: $523.8M; 2025: $526.5M.
What was Core Laboratories' net income in fiscal 2025?
Core Laboratories reported net income of $29.7M for fiscal 2025.
What was Core Laboratories' earnings per share (EPS) in fiscal 2025?
Core Laboratories' diluted EPS was $0.63 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Core Laboratories generate in fiscal 2025?
Core Laboratories generated $25.8M of free cash flow in fiscal 2025.
What was Core Laboratories' revenue last quarter?
In its most recent reported quarter (2026 Q2), Core Laboratories reported revenue of $124.6M.
How much debt does Core Laboratories have?
Core Laboratories reported $110.3M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Core Laboratories are outstanding?
Core Laboratories reported a weighted average of 46.0 million basic shares outstanding in 2026 Q2.
What is Core Laboratories' market cap?
Based on its latest closing price, Core Laboratories (CLB) has a market capitalization of about $476.3M.
When does Core Laboratories' fiscal year end?
Core Laboratories' fiscal year end, as registered with the SEC, is December 31.
Where is Core Laboratories headquartered?
Core Laboratories lists its business address in Houston, Texas in its SEC filings.